JP2021505691A5 - - Google Patents

Download PDF

Info

Publication number
JP2021505691A5
JP2021505691A5 JP2020552072A JP2020552072A JP2021505691A5 JP 2021505691 A5 JP2021505691 A5 JP 2021505691A5 JP 2020552072 A JP2020552072 A JP 2020552072A JP 2020552072 A JP2020552072 A JP 2020552072A JP 2021505691 A5 JP2021505691 A5 JP 2021505691A5
Authority
JP
Japan
Prior art keywords
disease
syndrome
arthritis
inflammation
autoimmune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020552072A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021505691A (ja
JP6987271B2 (ja
Filing date
Publication date
Priority claimed from CN201711309136.0A external-priority patent/CN109985030B/zh
Application filed filed Critical
Publication of JP2021505691A publication Critical patent/JP2021505691A/ja
Publication of JP2021505691A5 publication Critical patent/JP2021505691A5/ja
Application granted granted Critical
Publication of JP6987271B2 publication Critical patent/JP6987271B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020552072A 2017-12-11 2018-02-02 新規キノカルコン化合物、及びがん又は炎症を治療するためのその用途 Active JP6987271B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201711309136.0 2017-12-11
CN201711309136.0A CN109985030B (zh) 2017-12-11 2017-12-11 醌式查尔酮化合物在制备抗肿瘤药物中的应用
PCT/CN2018/075163 WO2019114125A1 (en) 2017-12-11 2018-02-02 A novel quinochalcone compound and uses thereof for treating cancer or inflammation

Publications (3)

Publication Number Publication Date
JP2021505691A JP2021505691A (ja) 2021-02-18
JP2021505691A5 true JP2021505691A5 (enExample) 2021-04-01
JP6987271B2 JP6987271B2 (ja) 2021-12-22

Family

ID=66819884

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020552072A Active JP6987271B2 (ja) 2017-12-11 2018-02-02 新規キノカルコン化合物、及びがん又は炎症を治療するためのその用途

Country Status (6)

Country Link
US (1) US10988429B2 (enExample)
EP (1) EP3675841B1 (enExample)
JP (1) JP6987271B2 (enExample)
CN (1) CN109985030B (enExample)
ES (1) ES2979333T3 (enExample)
WO (1) WO2019114125A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114409522B (zh) * 2022-03-01 2023-08-15 贵州省天然产物研究中心 一种查尔酮衍生物及其制备方法与用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013054998A1 (ko) * 2011-10-13 2013-04-18 건국대학교 산학협력단 신규한 칼콘 유도체 및 이를 유효성분으로 하는 항암제 조성물
CN105085218B (zh) * 2014-05-22 2019-04-09 中国医学科学院药物研究所 一类a环具有甲基的醌式查尔酮化合物，制法与抗炎活性
CN105085219B (zh) * 2014-05-22 2019-04-09 中国医学科学院药物研究所 A环具有异戊烯基的醌式查尔酮化合物，制法与抗炎活性

Similar Documents

Publication Publication Date Title
TW400233B (en) Pharmaceutical compositions comprising IL-12 antagonists for treating autoimmune diseases
US20080182845A1 (en) Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection
RU2472509C2 (ru) Способ лечения артрита
TW201718496A (zh) B型肝炎抗病毒劑之晶型
JP2014505095A5 (enExample)
JP2010502224A5 (enExample)
JP2020090515A (ja) 自己免疫疾患の処置
JP2022507506A5 (enExample)
US20160175316A1 (en) Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection
JP2021525729A5 (enExample)
CA3175420A1 (en) Methods for treating cytokine release syndrome
JP2020023558A (ja) ノカルダミンの新規金属錯体および医薬組成物におけるそれらの使用
JP2019529472A5 (enExample)
KR20250160942A (ko) 중증열성혈소판감소증후군 바이러스 감염증 치료제
JP7618642B2 (ja) インターロイキンの調節におけるプロドラッグ
JP2002515892A (ja) サイトカインが関係する疾患治療法
JP2004536079A5 (enExample)
KR101324451B1 (ko) 면역 조절제 활성을 갖는 화합물
ES2342946T3 (es) Indoloquinoxalinas sustituidas con alquilo.
JP2023528895A5 (enExample)
JP2005247821A (ja) 炎症性サイトカインの産生を抑制するための眼科用組成物
JP2025540166A (ja) 化合物、及びＴｒｅｇ関連疾患の治療におけるその使用
JP2023541261A5 (enExample)
JP2005527581A5 (enExample)
JP3029065B2 (ja) 免疫抑制剤としての５’−アミン置換アデノシン類似体